"10.1371_journal.pone.0089034","plos one","2014-02-20T00:00:00Z","Joel L Johnson; Yi Shi; Rose Snipes; Salim Janmohamed; Timothy E Rolfe; Bill Davis; Anthony Postle; Colin H Macphee","GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America; Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America; GlaxoSmithKline, Stockley Park, Middlesex, United Kingdom; GlaxoSmithKline, Addenbrook, Cambridge, United Kingdom; University of Southampton, Southampton, United Kingdom; GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America","Conceived and designed the experiments: RS SJ CHM BD. Performed the experiments: AP BD YS. Analyzed the data: TER. Contributed reagents/materials/analysis tools: AP. Wrote the paper: JLJ CHM.","I have read the journals policy and have the following conflicts: Joel L. Johnson: Full-time employee of and owns stock in GlaxoSmithKline. Yi Shi:Supported by GSK funds. Rose Snipes: Full-time employee of and owns stock in GlaxoSmithKline. Salim Janmohamed: Full-time employee of and owns stock in GlaxoSmithKline. Timothy E. Rolfe:Full-time employee of and owns stock in GlaxoSmithKline. Bill Davis: Full-time employee of and owns stock in GlaxoSmithKline. Anthony D. Postle (ADP): The mass spectrometry analysis of lysophosphatidylcholine included in the research described in this manuscript was supported by a grant for mass spectrometry instrumentation and consumables. The total value of support from GlaxoSmithKline for research in ADPs group between 2002 and 2013 was Â£725,000. ADP has had no personal financial benefit from his collaboration with GlaxoSmithKline. Colin H. Macphee:Full-time employee of and owns stock in GlaxoSmithKline. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Joel L Johnson","JLJ",8,TRUE,4,3,1,2,TRUE,FALSE,FALSE,0,NA,FALSE
